We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Roche Receives FDA Clearance for Zika Test
News

Roche Receives FDA Clearance for Zika Test

Roche Receives FDA Clearance for Zika Test
News

Roche Receives FDA Clearance for Zika Test

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Roche Receives FDA Clearance for Zika Test"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The product is for use in patients meeting CDC Zika virus clinical criteria and/or CDC Zika virus epidemiological criteria. The test is used for the detection of Zika virus in EDTA plasma or serum samples using Roche's LightCycler® 480 Instrument II or cobas z480 Analyzer.

"The LightMix Zika test is an easy-to-use molecular diagnostic test that enables healthcare professionals to quickly detect the virus," said Uwe Oberlaender, Head of Roche Molecular Diagnostics. "As a leader in diagnostics, Roche is committed to providing testing solutions for the world's most challenging healthcare emergencies. The FDA's granting of this EUA supports our commitment to help healthcare professionals who are working to combat this serious disease."

In addition to the LightMix® Zika rRT-PCR  Test, Roche has also developed the cobas® Zika Test for use with the cobas® 6800/8800 Systems.  This test is available under an Investigational New Drug Application (IND) protocol to initiate collection and testing of blood samples for screening.  It is currently being utilized in blood centres in the United States.

Advertisement